Drugs / Nafareline
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05484193 | Jun 2020 → Apr 2022 | — | Shaare Zedek Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nafareline | “using Nafareline (Synarel nasal spray 200mg used once)” NCT05484193 ↗ |
| Route | Intranasal | “intranasal GnRH-agonist” NCT05484193 ↗ |